MOST Training for Assisted Living and

Skilled Nursing/Long-Term Care Communities 

This on-demand learning goes over the Medical Orders for Scope of Treatment (MOST) form, a one-page, double-sided document that consolidates and translates patient preferences for key life-sustaining treatments (CPR, medical interventions and artificially-administered nutrition) into medical orders. The MOST form is always voluntary and is intended for patients who are at risk for a life-threatening clinical event because they have a serious life-limiting medical condition, which may include advanced frailty. This on-demand learning includes a post-training knowledge assessment to support your learning and implementation processes.

Time to Complete:

30 minutes


Target Audience: healthcare professionals, medical providers, surveyors

About the Telligen QI Connect™

Learning Management System (LMS)


This on-demand learning is available through the learning management system (LMS) section of the Telligen QI Connect™ Portal.


To access the on-demand learning, current Telligen QI Connect™ Portal users can log in to their existing Portal account and click on the blue hamburger menu in the top left corner to find the ‘My Learning’ button.



Non-Portal users can register for LMS access here. You will be emailed a username and password after you register. 

This material was prepared by Telligen, a Quality Innovation Network-Quality Improvement Organization, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS). Views expressed in this material do not necessarily reflect the official views or policy of CMS or HHS, and any reference to a specific product or entity herein does not constitute endorsement of that product or entity by CMS or HHS. This material is for informational purposes only and does not constitute medical advice; it is not intended to be a substitute for professional medical advice, diagnosis or treatment. 12SOW-QIN-01/30/24-5210

Questions? Respond directly to this email or visit our website for more information.